Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial.
作者： Ghassan K. Abou-Alfa , Philip Johnson , Jennifer J. Knox , Marinela Capanu , Irina Davidenko
关键词:
摘要: … the effect of doxorubicin plus sorafenib or doxorubicin plus … for patients with HCC treated with doxorubicin varies widely in the … HCC, treatment with sorafenib doxorubicin compared with …
sci-hub.se 参考文章(21)
Alireza S. Alavi, Lisette Acevedo, Wang Min, David A. Cheresh, Chemoresistance of Endothelial Cells Induced by Basic Fibroblast Growth Factor Depends on Raf-1–Mediated Inhibition of the Proapoptotic Kinase, ASK1 Cancer Research. ,vol. 67, pp. 2766- 2772 ,(2007) , 10.1158/0008-5472.CAN-06-3648
Josep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, Philip Hilgard, Edward Gane, Jean-Frédéric Blanc, Andre Cosme De Oliveira, Armando Santoro, Jean-Luc Raoul, Alejandro Forner, Myron Schwartz, Camillo Porta, Stefan Zeuzem, Luigi Bolondi, Tim F Greten, Peter R Galle, Jean-François Seitz, Ivan Borbath, Dieter Häussinger, Tom Giannaris, Minghua Shan, Marius Moscovici, Dimitris Voliotis, Jordi Bruix, None, Sorafenib in Advanced Hepatocellular Carcinoma The New England Journal of Medicine. ,vol. 359, pp. 378- 390 ,(2008) , 10.1056/NEJMOA0708857
Elio Sciarrino, Rosa Giovanna Simonetti, Salvatore Le Moli, Luigi Pagliaro, Adriamycin treatment for hepatocellular carcinoma. Experience with 109 patients. Cancer. ,vol. 56, pp. 2751- 2755 ,(1985) , 10.1002/1097-0142(19851215)56:12<2751::AID-CNCR2820561205>3.0.CO;2-O
J M Satagopan, L Ben-Porat, M Berwick, M Robson, D Kutler, A D Auerbach, A note on competing risks in survival data analysis British Journal of Cancer. ,vol. 91, pp. 1229- 1235 ,(2004) , 10.1038/SJ.BJC.6602102
G ABOUALFA, Hepatocellular Carcinoma: Molecular Biology and Therapy Seminars in Oncology. ,vol. 33, pp. 79- 83 ,(2006) , 10.1053/J.SEMINONCOL.2006.10.015
D. Maxwell Parkin,, Paola Pisani, Jacques Ferlay, Estimates of the worldwide incidence of 25 major cancers in 1990 International Journal of Cancer. ,vol. 80, pp. 827- 841 ,(1999) , 10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P
Robert J. Gray, A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk Annals of Statistics. ,vol. 16, pp. 1141- 1154 ,(1988) , 10.1214/AOS/1176350951
James A. McCubrey, Linda S. Steelman, Steven L. Abrams, John T. Lee, Fumin Chang, Fred E. Bertrand, Patrick M. Navolanic, David M. Terrian, Richard A. Franklin, Antonio B. D’Assoro, Jeffrey L. Salisbury, Maria Clorinda Mazzarino, Franca Stivala, Massimo Libra, Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance. Advances in Enzyme Regulation. ,vol. 46, pp. 249- 279 ,(2006) , 10.1016/J.ADVENZREG.2006.01.004
Ichiro Wakabayashi, Klaus Groschner, Vascular actions of anthracycline antibiotics. Current Medicinal Chemistry. ,vol. 10, pp. 427- 436 ,(2003) , 10.2174/0929867033368259
Mario E. Lacouture, Shenhong Wu, Caroline Robert, Michael B. Atkins, Heidi H. Kong, Joan Guitart, Claus Garbe, Axel Hauschild, Igor Puzanov, Doru T. Alexandrescu, Roger T. Anderson, Laura Wood, Janice P. Dutcher, Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib. Oncologist. ,vol. 13, pp. 1001- 1011 ,(2008) , 10.1634/THEONCOLOGIST.2008-0131